Geoffrion R, Yang EC, Koenig NA, Brotto LA, Barr AM, Lee T, et al. Recreational cannabis use before and after legalization in women with pelvic pain. Obstet Gynecol 2021;137.
The authors provided this information as a supplement to their article.
©2020 American College of Obstetricians and Gynecologists. Page 1 of 9
Appendix 1. Registry Characteristics by Willingness to Answer the Recreational Drug Usage Question
Recreational drug usage question
Variable Declined to answer (n=276) Answered (n=3426) P
Demographic
Age, mean (SD), years 35.0 (8.7) 34.8 (8.3) 0.791
Education, n (%) <0.001
Unknown 25 82
Below or some high school 14 (5.6) 115 (3.4)
Completed high school 102 (40.6) 1013 (30.3)
Completed college or university 93 (37.1) 1539 (46.0)
Completed graduate school 42 (16.7) 677 (20.2)
Household income, n (%) 0.228
Unknown 76 1093
Less than $20,000 36 (18.0) 328 (14.1)
$20,000-$39,999 39 (19.5) 383 (16.4)
$40,000-$59,999 29 (14.5) 359 (15.4)
$60,000-$79,999 30 (15.0) 359 (15.4)
$80,000-$99,999 27 (13.5) 285 (12.2)
$100,000 or more 39 (19.5) 619 (26.5)
Currently working, n (%) 0.405
Unknown 17 56
No (not because of pelvic pain) 38 (14.7) 473 (14.0)
No (because of pelvic pain) 39 (15.1) 417 (12.4)
Yes 182 (70.3) 2480 (73.6)
Marital Status - Married/Common law, n (%) 135/263 (51.3) 2133/3425 (62.3) <0.001
Ethnicity, n (%) 0.065
Unknown 9 7
Caucasian 179 (67.0) 2417 (70.7)
Black 0 (0.0) 16 (0.5)
Asian 44 (16.5) 468 (13.7)
Hispanic 2 (0.7) 92 (2.7)
Other 42 (15.7) 426 (12.5)
Smoke currently, n (%) 58/262 (22.1) 441/3426 (12.9) <0.001
Drink any alcohol, n (%) 176/262 (67.2) 2077/3426 (60.6) 0.036
BMI, mean (SD), kg/m2 25.2 (5.5) 25.7 (6.2) 0.182
# missing 6 64
Medical
Co-morbidities, n (%)^
Chronic fatigue syndrome 14/257 (5.4) 143/3333 (4.3) 0.382
Fibromyalgia 22/263 (8.4) 218/3373 (6.5) 0.232
Migraines, chronic headaches 62/263 (23.6) 800/3373 (23.7) 0.958
Taking opioids/narcotics every day because of pelvic pain, n (%) 32/266 (12.0) 406/3426 (11.9) 0.931
Medications for pelvic pain, n (%)^
Anti-inflammatories 236/273 (86.4) 2895/3421 (84.6) 0.420
Opioids/narcotics 119/271 (43.9) 1425/3371 (42.3) 0.599
Nerve medications 43/248 (17.3) 466/3243 (14.4) 0.202
Geoffrion R, Yang EC, Koenig NA, Brotto LA, Barr AM, Lee T, et al. Recreational cannabis use before and after legalization in women with pelvic pain. Obstet Gynecol 2021;137.
The authors provided this information as a supplement to their article.
©2020 American College of Obstetricians and Gynecologists. Page 2 of 9
Recreational drug usage question
Variable Declined to answer (n=276) Answered (n=3426) P
Muscle relaxants 9/275 (3.3) 172/3426 (5.0) 0.196
Herbal medications 27/275 (9.8) 307/3418 (9.0) 0.642
Gynecological
Parity, n (%) 0.322
Unknown 17 67
0 176 (68.0) 2141 (63.7)
1 41 (15.8) 486 (14.5)
2 31 (12.0) 531 (15.8)
3 9 (3.5) 151 (4.5)
4 or more 2 (0.8) 50 (1.5)
Age of onset of pelvic pain, mean (SD), years 19.9 (9.1) 20.9 (9.4) 0.125
# missing 65 1111
Previous hysterectomy, n (%) 28/271 (10.3) 300/3425 (8.8) 0.381
Post-menopausal, n (%) 7/251 (2.8) 38/3202 (1.2) 0.031
Endometriosis (suspected or confirmed), n (%) 212/275 (77.1) 2663/3420 (77.9) 0.766
Endometriosis stage, n (%) 0.935
Unknown 66 584
1 49 (33.6) 742 (35.7)
2 31 (21.2) 420 (20.2)
3 26 (17.8) 340 (16.4)
4 40 (27.4) 577 (27.8)
Other pain diagnoses
Abdominal wall trigger point, n (%) 86/266 (32.3) 942/3297 (28.6) 0.193
Pelvic floor myalgia, n (%) 94/270 (34.8) 1258/3350 (37.6) 0.371
Irritable bowel syndrome diagnosis, n (%) 164/275 (59.6) 1876/3426 (54.8) 0.118
Painful bladder syndrome diagnosis, n (%) 129/275 (46.9) 1577/3426 (46.0) 0.779
Validated questionnaires
PHQ-9, mean (SD) 9.9 (6.9) 9.0 (6.6) 0.024
# missing 15 28
GAD-7, mean (SD) 7.5 (6.0) 6.8 (5.6) 0.044
# missing 15 29
Pain catastrophizing scale, mean (SD) 22.3 (14.3) 21.3 (13.6) 0.245
# missing 15 25
EHP-30, mean (SD) 52.1 (24.7) 50.5 (24.0) 0.309
# missing 14 24
Pain score (severity of 3 or higher)
Painful menstrual cramps when bleeding, n (%) 264/275 (96.0) 3240/3426 (94.6) 0.310
Superficial dyspareunia, n (%) 141/275 (51.3) 1801/3426 (52.6) 0.679
Deep dyspareunia, n (%) 218/275 (79.3) 2714/3426 (79.2) 0.983
Dyschezia, n (%) 194/275 (70.5) 2306/3426 (67.3) 0.270
Other pelvic pain, n (%) 234/275 (85.1) 2949/3426 (86.1) 0.650
Back pain, n (%) 229/275 (83.3) 2804/3425 (81.9) 0.560
† Multiple categories can be selected for each woman.
Geoffrion R, Yang EC, Koenig NA, Brotto LA, Barr AM, Lee T, et al. Recreational cannabis use before and after legalization in women with pelvic pain. Obstet Gynecol 2021;137.
The authors provided this information as a supplement to their article.
©2020 American College of Obstetricians and Gynecologists. Page 3 of 9
For dichotomized variables with missing data, the denominator represents the number of women with non-missing data.
The “Declined to answer” group included those who did not provide an answer or selected “preferred not to answer”. Three women answered the recreational drug question but did not specify which drug they used and they were excluded from the current comparison.
Geoffrion R, Yang EC, Koenig NA, Brotto LA, Barr AM, Lee T, et al. Recreational cannabis use before and after legalization in women with pelvic pain. Obstet Gynecol 2021;137.
The authors provided this information as a supplement to their article.
©2020 American College of Obstetricians and Gynecologists. Page 4 of 9
Appendix 2. Registry Characteristics Between Cannabis Users and Nonusers in the Prelegalization and Postlegalization Periods
Prelegalization period Postlegalization period
Variable Cannabis users
(n=366) Non-users
(n=2394) P Cannabis users
(n=143) Non-users
(n=523) P
Demographic
Age, mean (SD), years 31.8 (7.8) 35.5 (8.3) <0.001 31.0 (7.6) 34.7 (7.8) <0.001
Education, n (%) <0.001 <0.001
Unknown 13 69 0 0
Below or some high school 26 (7.4) 86 (3.7) 1 (0.7) 2 (0.4)
Completed high school 171 (48.4) 742 (31.9) 33 (23.1) 67 (12.8)
Completed college or university 120 (34.0) 1013 (43.6) 95 (66.4) 311 (59.5)
Completed graduate school 36 (10.2) 484 (20.8) 14 (9.8) 143 (27.3)
Household income, n (%) <0.001 -
Unknown 58 374 142 519
Less than $20,000 68 (22.1) 260 (12.9) 0 (0.0) 0 (0.0)
$20,000-$39,999 63 (20.5) 318 (15.7) 0 (0.0) 2 (50.0)
$40,000-$59,999 61 (19.8) 297 (14.7) 1 (100.0) 0 (0.0)
$60,000-$79,999 43 (14.0) 315 (15.6) 0 (0.0) 1 (25.0)
$80,000-$99,999 28 (9.1) 257 (12.7) 0 (0.0) 0 (0.0)
$100,000 or more 45 (14.6) 573 (28.4) 0 (0.0) 1 (25.0)
Currently working, n (%) <0.001 <0.001
Unknown 12 44 0 0
No (not because of pelvic pain) 27 (7.6) 366 (15.6) 10 (7.0) 70 (13.4)
No (because of pelvic pain) 70 (19.8) 271 (11.5) 30 (21.0) 46 (8.8)
Yes 257 (72.6) 1713 (72.9) 103 (72.0) 407 (77.8)
Marital Status - Married/Common law, n (%) 184 (50.3) 1519 (63.5) <0.001 75/143 (52.4) 355/522 (68.0) <0.001
Ethnicity, n (%) <0.001 <0.001
Unknown
Caucasian 0
312 (85.2) 5
1642 (68.7) 2
113 (80.1) 0
350 (66.9)
Black 0 (0.0) 13 (0.5) 1 (0.7) 2 (0.4)
Asian 5 (1.4) 385 (16.1) 4 (2.8) 74 (14.1)
Hispanic 5 (1.4) 72 (3.0) 2 (1.4) 13 (2.5)
Other 44 (12.0) 277 (11.6) 21 (14.9) 84 (16.1)
Geoffrion R, Yang EC, Koenig NA, Brotto LA, Barr AM, Lee T, et al. Recreational cannabis use before and after legalization in women with pelvic pain. Obstet Gynecol 2021;137.
The authors provided this information as a supplement to their article.
©2020 American College of Obstetricians and Gynecologists. Page 5 of 9
Prelegalization period Postlegalization period
Variable Cannabis users
(n=366) Non-users
(n=2394) P Cannabis users
(n=143) Non-users
(n=523) P
Smoke currently, n (%) 112 (30.6) 258 (10.8) <0.001 29 (20.3) 42(8.0) <0.001
Drink any alcohol, n (%) 278 (76.0) 1384 (57.8) <0.001 107 (74.8) 308 (58.9) <0.001
BMI, mean (SD), kg/m2 25.6 (6.3) 25.6 (6.2) 0.898 26.6 (6.6) 26.0 (6.2) 0.305
# missing 7 51 3 3
Medical
Co-morbidities, n (%)†
Chronic fatigue syndrome 11/347 (3.2) 96/2320 (4.1) 0.392 9 (6.3) 27 (5.2) 0.596
Fibromyalgia 22/353 (6.2) 152/2354 (6.5) 0.872 10 (7.0) 34 (6.5) 0.834
Migraines, chronic headaches 71/353 (20.1) 533/2354 (22.6) 0.287 39 (27.3) 157 (30.0) 0.523
Daily opioids/narcotics use due to pelvic pain, n
(%) 68 (18.6) 294 (12.3) <0.001 15 (10.5) 29 (5.5) 0.035
Medications for pelvic pain, n (%)†
Anti-inflammatories 338/365 (92.6) 2107/2390 (88.2) 0.012 114 (79.7) 336 (64.2) <0.001
Opioids/narcotics 230/365 (63.0) 1056/2340 (45.1) <0.001 43 (30.1) 96 (18.4) 0.002
Nerve medications 68/334 (20.4) 347/2243 (15.5) 0.023 17 (11.9) 34 (6.5) 0.032
Muscle relaxants 21 (5.7) 127 (5.3) 0.732 6 (4.2) 18 (3.4) 0.668
Herbal medications 74/366 (20.2) 128/2391 (5.4) <0.001 44/142 (31.0) 61/519 (11.8) <0.001
Gynecological
Parity, n (%) <0.001 0.071
Unknown 10 49 0 8
0 258 (72.5) 1436 (61.2) 108 (75.5) 339 (65.8)
1 40 (11.2) 355 (15.1) 20 (14.0) 71 (13.8)
2 34 (9.6) 408 (17.4) 13 (9.1) 76 (14.8)
3 19 (5.3) 107 (4.6) 2 (1.4) 23 (4.5)
4 or more 5 (1.4) 39 (1.7) 0 (0.0) 6 (1.2)
Age of onset of pelvic pain, mean (SD), years 19.1 (7.7) 21.2 (9.6) <0.001 - 19.8 (10.8) -
# missing 59 392 142 518
Previous hysterectomy, n (%) 41/366 (11.2) 223/2393 (9.3) 0.254 8 (5.6) 28 (5.4) 0.910
Post-menopausal, n (%) 0/335 (0.0) 34/2203 (1.5) 0.022 0/143 (0.0) 4/521 (0.8) 0.582
Endometriosis (suspected or confirmed), n (%) 295/366 (80.6) 1835/2392 (76.7) 0.099 107/142 (75.4) 426/520 (81.9) 0.080
Endometriosis stage, n (%) 0.017 0.351
Geoffrion R, Yang EC, Koenig NA, Brotto LA, Barr AM, Lee T, et al. Recreational cannabis use before and after legalization in women with pelvic pain. Obstet Gynecol 2021;137.
The authors provided this information as a supplement to their article.
©2020 American College of Obstetricians and Gynecologists. Page 6 of 9
Prelegalization period Postlegalization period
Variable Cannabis users
(n=366) Non-users
(n=2394) P Cannabis users
(n=143) Non-users
(n=523) P
Unknown 82 502 0 0
1 88 (41.3) 467 (35.0) 34 (31.8) 153 (35.9)
2 49 (23.0) 245 (18.4) 29 (27.1) 97 (22.8)
3 35 (16.4) 240 (18.0) 9 (8.4) 56 (13.1)
4 41 (19.2) 381 (28.6) 35 (32.7) 120 (28.2)
Other pain diagnoses
Abdominal wall trigger point 123/354 (34.7) 657/2293 (28.7) 0.019 45/137 (32.8) 117/513 (22.8) 0.016
Pelvic floor myalgia 149/361 (41.3) 827/2338 (35.4) 0.030 71/140 (50.7) 211/511 (41.3) 0.046
Irritable bowel syndrome diagnosis 226 (61.7) 1272 (53.1) 0.002 91 (63.6) 287 (54.9) 0.061
Painful bladder syndrome diagnosis 190 (51.9) 1079 (45.1) 0.014 75 (52.4) 233 (44.6) 0.093
Validated questionnaires PHQ-9, mean (SD)
#missing 11.3 (6.7)
4 8.5 (6.5)
20 <0.001 12.5 (7.1)
2 8.4 (6.4)
2 <0.001 GAD-7, mean (SD)
#missing 8.4 (5.7)
4 6.4 (5.6)
21 <0.001 9.6 (5.9)
2 6.4 (5.4)
2 <0.001 Pain catastrophizing scale, mean (SD)
#missing 23.4 (12.4)
4 20.0 (13.7)
21 <0.001 27.9 (12.5)
0 24.0 (13.2)
0 0.002
EHP-30, mean (SD)
#missing 57.1 (20.7)
4 49.3 (24.0)
18 <0.001 59.3 (22.2)
1 49.1 (25.6)
1 <0.001 Pain score (severity of 3 or higher)
Painful menstrual cramps when bleeding, n (%) 355 (97.0) 2234 (93.3) 0.007 140 (97.9) 511 (97.7) 0.888
Superficial dyspareunia, n (%) 191 (52.2) 1285 (53.7) 0.595 73 (51.0) 252 (48.2) 0.544
Deep dyspareunia, n (%) 312 (85.2) 1860 (77.7) 0.001 123 (86.0) 419 (80.1) 0.108
Dyschezia, n (%) 288 (78.7) 1564 (65.3) <0.001 112 (78.3) 342 (65.4) 0.003
Other pelvic pain, n (%) 339 (92.6) 2038 (85.1) <0.001 135 (94.4) 437 (83.6) <0.001
Back pain, n (%) 334 (91.3) 1918 (80.1) <0.001 130/143 (90.9) 422/522 (80.8) 0.005
† Multiple categories can be selected for each woman.
For dichotomized variables with missing data, the denominator represents the number of women with non-missing data.
Geoffrion R, Yang EC, Koenig NA, Brotto LA, Barr AM, Lee T, et al. Recreational cannabis use before and after legalization in women with pelvic pain. Obstet Gynecol 2021;137.
The authors provided this information as a supplement to their article.
©2020 American College of Obstetricians and Gynecologists. Page 7 of 9
Appendix 3. Registry Characteristics Between Cannabis Users and Nonusers by Endometriosis
Without endometriosis With endometriosis
Variable Cannabis users (n=106) Non-users (n=651) P Cannabis users (n=402) Non-users (n=2261) P
Demographic
Age, mean (SD), years 33.7 (9.1) 37.0 (9.0) <0.001 31.1 (7.3) 34.9 (8.0) <0.001
Education, n (%) <0.001 <0.001
Unknown 5 22 8 47
Below or some high school 14 (13.9) 35 (5.6) 13 (3.3) 53 (2.4)
Completed high school 43 (42.6) 213 (33.9) 160 (40.6) 595 (26.9)
Completed college or university 36 (35.6) 261 (41.5) 179 (45.4) 1061 (47.9)
Completed graduate school 8 (7.9) 120 (19.1) 42 (10.7) 505 (22.8)
Household income, n (%) <0.001 <0.001
Unknown 40 151 159 737
Less than $20,000 21 (31.8) 83 (16.6) 47 (19.3) 177 (11.6)
$20,000-$39,999 15 (22.7) 65 (13.0) 48 (19.8) 255 (16.7)
$40,000-$59,999 11 (16.7) 65 (13.0) 51 (21.0) 232 (15.2)
$60,000-$79,999 10 (15.2) 83 (16.6) 33 (13.6) 233 (15.3)
$80,000-$99,999 3 (4.5) 63 (12.6) 25 (10.3) 194 (12.7)
$100,000 or more 6 (9.1) 141 (28.2) 39 (16.0) 433 (28.4)
Currently working, n (%) <0.001 <0.001
Unknown 0 8 12 36
No (not because of pelvic pain) 11 (10.4) 119 (18.5) 26 (6.7) 316 (14.2)
No (because of pelvic pain) 31 (29.2) 94 (14.6) 68 (17.4) 223 (10.0)
Yes 64 (60.4) 430 (66.9) 296 (75.9) 1686 (75.8)
Marital Status - Married/Common law, n (%) 48 (45.3) 405 (62.2) <0.001 211/402 (52.5) 1465/2260 (64.8) <0.001
Ethnicity, n (%) <0.001 <0.001
Unknown 0 1 2 4
Caucasian 94 (88.7) 476 (73.2) 330 (82.5) 1516 (67.2)
Black 0 (0.0) 5 (0.8) 1 (0.3) 10 (0.4)
Asian 1 (0.9) 68 (10.5) 8 (2.0) 390 (17.3)
Hispanic 0 (0.0) 15 (2.3) 7 (1.8) 70 (3.1)
Other 11 (10.4) 86 (13.2) 54 (13.5) 271 (12.0)
Smoke currently, n (%) 38 (35.8) 87 (13.4) <0.001 103 (25.6) 213 (9.4) <0.001
Geoffrion R, Yang EC, Koenig NA, Brotto LA, Barr AM, Lee T, et al. Recreational cannabis use before and after legalization in women with pelvic pain. Obstet Gynecol 2021;137.
The authors provided this information as a supplement to their article.
©2020 American College of Obstetricians and Gynecologists. Page 8 of 9
Without endometriosis With endometriosis
Variable Cannabis users (n=106) Non-users (n=651) P Cannabis users (n=402) Non-users (n=2261) P
Drink any alcohol, n (%) 76 (71.7) 369 (56.7) 0.004 309 (76.9) 1321 (58.4) <0.001
BMI, mean (SD), kg/m2 26.9 (6.8) 25.9 (6.8) 0.189 25.7 (6.3) 25.6 (6.0) 0.842
# missing 3 31 6 21
Medical
Co-morbidities, n (%)^
Chronic fatigue syndrome 3/106 (2.8) 38/633 (6.0) 0.187 17/383 (4.4) 85/2205 (3.9) 0.588
Fibromyalgia 11/103 (10.7) 48/639 (7.5) 0.270 21/392 (5.4) 138/2233 (6.2) 0.529
Migraines, chronic headaches 28/103 (27.2) 150/639 (23.5) 0.413 81/392 (20.7) 539/2233 (24.1) 0.135
Taking opioids/narcotics every day because of
pelvic pain, n (%) 30 (28.3) 91 (14.0) <0.001 53 (13.2) 232 (10.3) 0.081
Medications for pelvic pain, n (%)^
Anti-inflammatories 91/106 (85.8) 538/649 (82.9) 0.450 360/401 (89.8) 1902/2259 (84.2) 0.004
Opioids/narcotics 65/106 (61.3) 276/641 (43.1) <0.001 207/401 (51.6) 875/2217 (39.5) <0.001
Nerve medications 27/101 (26.7) 116/619 (18.7) 0.062 57/375 (15.2) 265/2142 (12.4) 0.130
Muscle relaxants 8 (7.5) 34 (5.2) 0.332 19 (4.7) 110 (4.9) 0.905
Herbal medications 17/106 (16.0) 39/650 (6.0) <0.001 101/401 (25.2) 150/2255 (6.7) <0.001
Gynecological
Parity, n (%) 0.520 <0.001
Unknown 1 22 9 35
0 59 (56.2) 318 (50.6) 306 (77.9) 1453 (65.3)
1 17 (16.2) 99 (15.7) 43 (10.9) 326 (14.6)
2 17 (16.2) 137 (21.8) 30 (7.6) 347 (15.6)
3 10 (9.5) 50 (7.9) 11 (2.8) 80 (3.6)
4 or more 2 (1.9) 25 (4.0) 3 (0.8) 20 (0.9)
Age of onset of pelvic pain, mean (SD), years 21.8 (9.3) 23.9 (11.3) 0.147 18.3 (7.0) 20.3 (8.8) <0.001
# missing 40 159 160 746
Previous hysterectomy, n (%) 20/106 (18.9) 92/650 (14.2) 0.205 29 (7.2) 159 (7.0) 0.896
Post-menopausal, n (%) 0/95 (0.0) 19/591 (3.2) 0.076 0/382 (0.0) 19/2128 (0.9) 0.064
Endometriosis (suspected or confirmed), n (%) 0 (0.0) 0 (0.0) - 402 (100.0) 2261 (100.0) -
Endometriosis stage, n (%) - 0.054
Unknown - - 82 502
1 - - 122 (38.1) 620 (35.2)
Geoffrion R, Yang EC, Koenig NA, Brotto LA, Barr AM, Lee T, et al. Recreational cannabis use before and after legalization in women with pelvic pain. Obstet Gynecol 2021;137.
The authors provided this information as a supplement to their article.
©2020 American College of Obstetricians and Gynecologists. Page 9 of 9
Without endometriosis With endometriosis
Variable Cannabis users (n=106) Non-users (n=651) P Cannabis users (n=402) Non-users (n=2261) P
2 - - 78 (24.4) 342 (19.4)
3 - - 44 (13.8) 296 (16.8)
4 - - 76 (23.8) 501 (28.5)
Other pain diagnoses
Abdominal wall trigger point, n (%) 30/95 (31.6) 158/589 (26.8) 0.336 138/396 (34.8) 616/2216 (27.8) 0.004
Pelvic floor myalgia, n (%) 48/104 (46.2) 218/632 (34.5) 0.022 172/396 (43.4) 820/2213 (37.1) 0.016
Irritable bowel syndrome diagnosis, n (%) 48 (45.3) 267 (41.0) 0.408 216 (53.7) 1043 (46.1) 0.005
Painful bladder syndrome diagnosis, n (%) 25/97 (25.8) 128/626 (20.4) 0.232 77/376 (20.5) 369/2092 (17.6) 0.188
Validated questionnaires
PHQ-9, mean (SD) 11.6 (6.9) 8.5 (6.6) <0.001 11.6 (6.8) 8.5 (6.4) <0.001
# missing 2 8 4 14
GAD-7, mean (SD) 8.2 (6.0) 6.0 (5.4) <0.001 8.9 (5.8) 6.6 (5.5) <0.001
# missing 2 8 4 15
Pain catastrophizing scale, mean (SD) 26.0 (12.7) 20.2 (13.6) <0.001 24.3 (12.5) 20.8 (13.7) <0.001
# missing 1 7 3 14
EHP-30, mean (SD) 60.3 (22.5) 48.7 (25.4) <0.001 57.0 (20.7) 49.4 (23.9) <0.001
# missing 1 6 4 13
Pain score (severity of 3 or higher)
Painful menstrual cramps when bleeding, n (%) 63 (59.4) 398 (61.1) 0.739 318 (79.1) 1714 (75.8) 0.152
Superficial dyspareunia, n (%) 61 (57.5) 337 (51.8) 0.269 203 (50.5) 1197 (52.9) 0.366
Deep dyspareunia, n (%) 86 (81.1) 480 (73.7) 0.104 349 (86.8) 1796 (79.4) <0.001
Dyschezia, n (%) 82 (77.4) 378 (58.1) <0.001 317 (78.9) 1526 (67.5) <0.001
Other pelvic pain, n (%) 100 (94.3) 550 (84.5) 0.007 373 (92.8) 1920 (84.9) <0.001
Back pain, n (%) 100/106 (94.3) 498/650 (76.6) <0.001 363 (90.3) 1841 (81.4) <0.001
† Multiple categories can be selected for each woman.
For dichotomized variables with missing data, the denominator represents the number of women with non-missing data.